Life sciences company Lonza Group Ltd., with headquarters in Basel, Switzerland, completed its acquisition of Arch Chemicals Inc., based in Norwalk, Conn., in October.
Lonza is a supplier of pharmaceutical ingredients to the nutrition, hygiene, preservation, agriculture and personal care markets. It purchased more than 90% of the outstanding shares of Arch Chemicals common stock and acquired the company through a short-form merger. Arch is a maker of chemicals used to kill micro-organisms and fungi. Its products are sometimes used in bedding components.
Arch is now an indirect, wholly-owned subsidiary of Lonza, which has formed the new business Lonza Microbial Control led by Jeanne Thoma. The new company provides solutions for microbial-control needs.
“After having built the world’s leading pharmaceutical contract manufacturer over the past years, we, as of today, are also the world’s leading microbial control business,” said Stefan Borgas, Lonza chief executive officer. “This step enhances our global footprint and balances our currencies and our business models.”
